Abstract:Purpose: To investigate the usefulness of computed tomographic (CT) spectral imaging parameters in differentiating small (<= 3 cm) hepatic hemangioma (HH) from small hepatocellular carcinoma (HCC), with or without cirrhosis, during the late arterial phase (AP) and portal venous phase (PVP).Materials and Methods: This prospective study was institutional review board approved, and written informed consent was obtained from all patients. The authors examined 49 patients (39 men, 10 women; 65 lesions) with CT spectral imaging during the AP and the PVP. Twenty-one patients had HH; nine, HCC with cirrhosis; and 19, HCC without cirrhosis. Iodine concentrations were derived from iodine-based material-decomposition CT images and normalized to the iodine concentration in the aorta. The difference in iodine concentration between the AP and PVP (ie, iodine concentration difference [ICD]) and the lesion-to-normal parenchyma ratio (LNR) were calculated. Two readers qualitatively assessed lesion types on the basis of conventional CT characteristics. Sensitivity and specificity were compared between the qualitative and quantitative studies. The two-sample t test was performed to compare quantitative parameters between HH and HCC.Results: Normalized iodine concentrations (NICs) and LNRs in patients with HH differed significantly from those in patients with HCC and cirrhosis and those in patients with HCC without cirrhosis: Mean NICs were 0.47 mg/mL +/- 0.24 (standard deviation) versus 0.23 mg/mL +/- 0.10 and 0.23 mg/mL +/- 0.08, respectively, during the AP and 0.83 mg/mL +/- 0.38 versus 0.47 mg/mL +/- 0.86 and 0.52 mg/mL +/- 0.11, respectively, during the PVP. Mean LNRs were 5.87 +/- 3.36 versus 2.56 +/- 1.10 and 2.29 +/- 0.87, respectively, during the AP and 2.01 +/- 1.33 versus 0.96 +/- 0.16 and 0.93 +/- 0.26, respectively, during the PVP. The mean ICD for the HH group (1.37 mg/mL +/- 0.84) was significantly higher than the mean ICDs for the HCC-cirrhosis (0.33 mg/mL +/- 0.29) (P < .001) and HCC-no cirrhosis (0.82 mg/mL +/- 0.99) (P = .03) groups. The combination of NIC and LNR had higher sensitivity and specificity compared with those of conventional qualitative CT image analysis during individual and combined phases.Conclusion: Use of spectral CT with fast tube voltage switching may increase the sensitivity for differentiating small hemangiomas from small HCCs in two-phase scanning. (C) RSNA, 2011

Differentiation of Neoplastic from Bland Macroscopic Portal Vein Thrombi Using Dual-Energy Spectral CT Imaging: a Pilot Study.

Differentiation of lung cancers from inflammatory masses with dual-energy spectral CT imaging.

Differentiating malignant and benign necrotic lung lesions using kVp-switching dual-energy spectral computed tomography

Differentiating malignant vertebral tumours from non-malignancies with CT spectral imaging: a preliminary study

Value of Combined Model of Clinical and Imaging Based on Dual-Energy CT for Differentiating Benign and Malignant Portal Vein Embolus

Evaluation of Dual Energy Spectral CT in Differentiating Metastatic from Non-Metastatic Lymph Nodes in Rectal Cancer: Initial Experience

Differentiating peripheral lung cancers from inflammatory masses using dual energy spectral CT imaging

Dual-Energy CT for the Detection of Portal Vein Thrombosis: Improved Diagnostic Performance Using Virtual Monoenergetic Reconstructions

Gastric Cancer Staging With Dual Energy Spectral Ct Imaging

Differentiation of Bland from Neoplastic Thrombus of the Portal Vein in Patients with Hepatocellular Carcinoma: Application of Susceptibility-Weighted MR Imaging.

Quantitative Assessment of the Degree of Differentiation in Colon Cancer with Dual-Energy Spectral CT.

Differentiating malignant from benign gastric mucosal lesions with quantitative analysis in dual energy spectral computed tomography: Initial experience.

Multiparametric Dual-Energy CT to Differentiate Stage T1 Nasopharyngeal Carcinoma from Benign Hyperplasia.

Dual-energy CT Portal Venography: Clinical Application Values and Future Opportunities

Differentiation of Hepatocellular Carcinoma from Hepatic Hemangioma and Focal Nodular Hyperplasia Using Computed Tomographic Spectral Imaging

Can Spectral Ct Imaging Improve The Differentiation Between Malignant And Benign Solitary Pulmonary Nodules?

Differentiation of Hamartomas and Malignant Lung Tumors in Single-Phased Dual-Energy Computed Tomography

Dual Energy Spectral CT Imaging in the Assessment of Gastric Cancer and Cell Proliferation: A Preliminary Study

Preliminary Evaluation of Dual-Energy CT Technique in the Study of Solitary Pulmonary Nodules

Dual-energy CT quantitative parameters for the differentiation of benign from malignant lesions and the prediction of histopathological and molecular subtypes in breast cancer

Differentiation of Small Hepatic Hemangioma from Small Hepatocellular Carcinoma: Recently Introduced Spectral Ct Method